Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Peptic Ulcer

Free Subscription Articles published in Gut Retrieve available abstracts of 36 articles: HTML format

Single Articles

November 2022
1. BORNSCHEIN J, Pritchard DM, Malfertheiner P
   Letter to the editor: Helicobacter pylori eradication - the proof is not in the symptoms.
   Gut. 2022 Nov 15. pii: gutjnl-2022-329057. doi: 10.1136/gutjnl-2022-329057.
   PubMed    
   
   
   October 2022
2. CHAN S, Pittayanon R, Wang HP, Chen JH, et al
   Use of over-the-scope clip (OTSC) versus standard therapy for the prevention of rebleeding in large peptic ulcers (size >/=1.5 cm): an open-labelled, multicentre international randomised controlled trial.
   Gut. 2022 Oct 28. pii: gutjnl-2022-327007. doi: 10.1136/gutjnl-2022-327007.
   PubMed     Abstract available
   
   
   August 2022
3. MALFERTHEINER P, Megraud F, Rokkas T, Gisbert JP, et al
   Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report.
   Gut. 2022 Aug 8. pii: gutjnl-2022-327745. doi: 10.1136/gutjnl-2022-327745.
   PubMed     Abstract available
   
   
   June 2022
4. RUGGE M, Bricca L, Guzzinati S, Sacchi D, et al
   Autoimmune gastritis: long-term natural history in naive Helicobacter pylori-negative patients.
   Gut. 2022 Jun 30. pii: gutjnl-2022-327827. doi: 10.1136/gutjnl-2022-327827.
   PubMed     Abstract available
   
   
   April 2022
5. KALAPALA R, Karyampudi A, Nabi Z, Darisetty S, et al
   Endoscopic full-thickness plication for the treatment of PPI-dependent GERD: results from a randomised, sham controlled trial.
   Gut. 2022;71:686-694.
   PubMed     Abstract available
   
   
   March 2022
6. MEIER B, Wannhoff A, Denzer U, Stathopoulos P, et al
   Over-the-scope-clips versus standard treatment in high-risk patients with acute non-variceal upper gastrointestinal bleeding: a randomised controlled trial (STING-2).
   Gut. 2022 Mar 23. pii: gutjnl-2021-325300. doi: 10.1136/gutjnl-2021-325300.
   PubMed     Abstract available
   
   
   January 2022
7. FORD AC, Tsipotis E, Yuan Y, Leontiadis GI, et al
   Efficacy of Helicobacter pylori eradication therapy for functional dyspepsia: updated systematic review and meta-analysis.
   Gut. 2022 Jan 12. pii: gutjnl-2021-326583. doi: 10.1136/gutjnl-2021-326583.
   PubMed     Abstract available
   
   
   December 2021
8. DONG C, Lee YH, Tan TY, Yao CC, et al
   Correspondence to proton pump inhibitors and risk of colorectal cancer.
   Gut. 2021 Dec 2. pii: gutjnl-2021-326139. doi: 10.1136/gutjnl-2021-326139.
   PubMed    
   
   
   
9. ABRAHAMI D, Azoulay L
   Response by Abrahami et al to letter regarding article 'Proton pump inhibitors and risk of colorectal cancer'.
   Gut. 2021 Dec 2. pii: gutjnl-2021-326544. doi: 10.1136/gutjnl-2021-326544.
   PubMed    
   
   
   
10. ZERBIB F
    Diagnosis of GORD: is the 'grey area' expanding?
    Gut. 2021;70:2221-2222.
    PubMed    
    
    
    
11. RUSU RI, Fox MR, Tucker E, Zeki S, et al
    Validation of the Lyon classification for GORD diagnosis: acid exposure time assessed by prolonged wireless pH monitoring in healthy controls and patients with erosive oesophagitis.
    Gut. 2021;70:2230-2237.
    PubMed     Abstract available
    
    
    November 2021
12. ZENG R, Sha W, Wang J, Zhuo Z, et al
    Evaluation of proton pump inhibitors and risks of gastric cancer.
    Gut. 2021 Nov 26. pii: gutjnl-2021-326291. doi: 10.1136/gutjnl-2021-326291.
    PubMed    
    
    
    
13. DING SZ, Du YQ, Lu H, Wang WH, et al
    Chinese Consensus Report on Family-Based Helicobacter pylori Infection Control and Management (2021 Edition).
    Gut. 2021 Nov 26. pii: gutjnl-2021-325630. doi: 10.1136/gutjnl-2021-325630.
    PubMed     Abstract available
    
    
    
14. LOOSEN SH, Kostev K, Luedde M, Qvartskhava N, et al
    Long-term use of proton pump inhibitors (PPIs) is associated with an increased risk of type 2 diabetes.
    Gut. 2021 Nov 1. pii: gutjnl-2021-326297. doi: 10.1136/gutjnl-2021-326297.
    PubMed    
    
    
    October 2021
15. SHAH S, Halvorson A, McBay B, Dorn C, et al
    Proton-pump inhibitor use is not associated with severe COVID-19-related outcomes: a propensity score-weighted analysis of a national veteran cohort.
    Gut. 2021 Oct 18. pii: gutjnl-2021-325701. doi: 10.1136/gutjnl-2021-325701.
    PubMed    
    
    
    September 2021
16. GUO CLT, Wong SH, Lau LHS, Lui RNS, et al
    Timing of endoscopy for acute upper gastrointestinal bleeding: a territory-wide cohort study.
    Gut. 2021 Sep 21. pii: gutjnl-2020-323054. doi: 10.1136/gutjnl-2020-323054.
    PubMed     Abstract available
    
    
    August 2021
17. ARAI J, Niikura R, Hayakawa Y, Aoki T, et al
    OLGIM staging and proton pump inhibitor use predict the risk of gastric cancer.
    Gut. 2021 Aug 3. pii: gutjnl-2021-325551. doi: 10.1136/gutjnl-2021-325551.
    PubMed    
    
    
    July 2021
18. PATEL J, Berezowski I, Janapala RN, Pourmand A, et al
    Proton pump inhibitors and gastric cancer: a population-based cohort study.
    Gut. 2021 Jul 14. pii: gutjnl-2021-325385. doi: 10.1136/gutjnl-2021-325385.
    PubMed    
    
    
    
19. OSTER P, Vaillant L, Riva E, McMillan B, et al
    Helicobacter pylori infection has a detrimental impact on the efficacy of cancer immunotherapies.
    Gut. 2021 Jul 12. pii: gutjnl-2020-323392. doi: 10.1136/gutjnl-2020-323392.
    PubMed     Abstract available
    
    
    
20. ABRAHAMI D, McDonald EG, Schnitzer ME, Barkun AN, et al
    Proton pump inhibitors and risk of gastric cancer: population-based cohort study.
    Gut. 2021 Jul 5. pii: gutjnl-2021-325097. doi: 10.1136/gutjnl-2021-325097.
    PubMed     Abstract available
    
    
    
21. ABRAHAMI D, McDonald EG, Schnitzer ME, Barkun AN, et al
    Proton pump inhibitors and risk of colorectal cancer.
    Gut. 2021 Jul 1. pii: gutjnl-2021-325096. doi: 10.1136/gutjnl-2021-325096.
    PubMed     Abstract available
    
    
    June 2021
22. ONG JS, An J, Han X, Law MH, et al
    Multitrait genetic association analysis identifies 50 new risk loci for gastro-oesophageal reflux, seven new loci for Barrett's oesophagus and provides insights into clinical heterogeneity in reflux diagnosis.
    Gut. 2021 Jun 29. pii: gutjnl-2020-323906. doi: 10.1136/gutjnl-2020-323906.
    PubMed     Abstract available
    
    
    May 2021
23. SEO SI, Park CH, You SC, Kim JY, et al
    Association between proton pump inhibitor use and gastric cancer: a population-based cohort study using two different types of nationwide databases in Korea.
    Gut. 2021 May 11. pii: gutjnl-2020-323845. doi: 10.1136/gutjnl-2020-323845.
    PubMed     Abstract available
    
    
    April 2021
24. MEGRAUD F, Bruyndonckx R, Coenen S, Wittkop L, et al
    Helicobacter pylori resistance to antibiotics in Europe in 2018 and its relationship to antibiotic consumption in the community.
    Gut. 2021 Apr 9. pii: gutjnl-2021-324032. doi: 10.1136/gutjnl-2021-324032.
    PubMed     Abstract available
    
    
    
25. NIENHUSER H, Kim W, Malagola E, Ruan T, et al
    Mist1+ gastric isthmus stem cells are regulated by Wnt5a and expand in response to injury and inflammation in mice.
    Gut. 2021;70:654-665.
    PubMed     Abstract available
    
    
    March 2021
26. SUNG JJY, Laine L, Kuipers EJ, Barkun AN, et al
    Towards personalised management for non-variceal upper gastrointestinal bleeding.
    Gut. 2021 Mar 1. pii: gutjnl-2020-323846. doi: 10.1136/gutjnl-2020-323846.
    PubMed     Abstract available
    
    
    December 2020
27. SPILLER RC, Jalanka J
    Brachyspira and IBS with diarrhoea: a Helicobacter pylori moment?
    Gut. 2020 Dec 24. pii: gutjnl-2020-323370. doi: 10.1136/gutjnl-2020-323370.
    PubMed    
    
    
    
28. HE Q, Yang M, Qin X, Fan D, et al
    Risk stratification for proton pump inhibitor-associated type 2 diabetes: a population-based cohort study.
    Gut. 2020 Dec 22. pii: gutjnl-2020-323816. doi: 10.1136/gutjnl-2020-323816.
    PubMed    
    
    
    
29. LU TX, Dapas M, Lin E, Peters T, et al
    The influence of proton pump inhibitor therapy on the outcome of infliximab therapy in inflammatory bowel disease: a patient-level meta-analysis of randomised controlled studies.
    Gut. 2020 Dec 17. pii: gutjnl-2020-321609. doi: 10.1136/gutjnl-2020-321609.
    PubMed     Abstract available
    
    
    
30. LEE SW, Yang JM, Yoo IK, Moon SY, et al
    Proton pump inhibitors and the risk of severe COVID-19: a post-hoc analysis from the Korean nationwide cohort.
    Gut. 2020 Dec 10. pii: gutjnl-2020-323672. doi: 10.1136/gutjnl-2020-323672.
    PubMed    
    
    
    
31. ZHOU J, Wang X, Lee S, Wu WKK, et al
    Proton pump inhibitor or famotidine use and severe COVID-19 disease: a propensity score-matched territory-wide study.
    Gut. 2020 Dec 4. pii: gutjnl-2020-323668. doi: 10.1136/gutjnl-2020-323668.
    PubMed    
    
    
    November 2020
32. LI GF, An XX, Yu Y, Jiao LR, et al
    Do proton pump inhibitors influence SARS-CoV-2 related outcomes? A meta-analysis.
    Gut. 2020 Nov 10. pii: gutjnl-2020-323366. doi: 10.1136/gutjnl-2020-323366.
    PubMed    
    
    
    October 2020
33. LIOU JM, Malfertheiner P, Lee YC, Sheu BS, et al
    Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus.
    Gut. 2020 Oct 1. pii: gutjnl-2020-322368. doi: 10.1136/gutjnl-2020-322368.
    PubMed     Abstract available
    
    
    September 2020
34. ZHOU X, Zhu H, Chen Y, Li Z, et al
    Role of Helicobacter pylori in gastric diseases pathogenesis cannot be ignored.
    Gut. 2020 Sep 29. pii: gutjnl-2020-322629. doi: 10.1136/gutjnl-2020-322629.
    PubMed    
    
    
    
35. YUAN J, He Q, Nguyen LH, Wong MCS, et al
    Regular use of proton pump inhibitors and risk of type 2 diabetes: results from three prospective cohort studies.
    Gut. 2020 Sep 28. pii: gutjnl-2020-322557. doi: 10.1136/gutjnl-2020-322557.
    PubMed     Abstract available
    
    
    April 2020
36. WONG GLH, Lau LHS, Ching JYL, Tse YK, et al
    Prevention of recurrent idiopathic gastroduodenal ulcer bleeding: a double-blind, randomised trial.
    Gut. 2020;69:652-657.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Peptic Ulcer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: